These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26905396)

  • 1. An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination.
    Wilson K; Atkinson KM; Westeinde J; Bell C; Marty K; Fergusson D; Deeks SL; Crowcroft N; Bettinger JA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1738-48. PubMed ID: 26905396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. User preferences for a mobile application to report adverse events following vaccination.
    Nguyen MTH; Ott JJ; Caputo M; Keller-Stanislawski B; Klett-Tammen CJ; Linnig S; Mentzer D; Krause G
    Pharmazie; 2020 Jan; 75(1):27-31. PubMed ID: 32033630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial.
    Bota AB; Bettinger JA; Sarfo-Mensah S; Lopez J; Smith DP; Atkinson KM; Bell C; Marty K; Serhan M; Zhu DT; McCarthy AE; Wilson K
    JMIR Public Health Surveill; 2023 May; 9():e39700. PubMed ID: 37155240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.
    Bettinger JA; De Serres G; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; Top KA; Isenor JE; McCarthy AE;
    Euro Surveill; 2020 Jun; 25(22):. PubMed ID: 32524947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmarketing Safety Monitoring After Influenza Vaccination Using a Mobile Health App: Prospective Longitudinal Feasibility Study.
    Nguyen MTH; Krause G; Keller-Stanislawski B; Glöckner S; Mentzer D; Ott JJ
    JMIR Mhealth Uhealth; 2021 May; 9(5):e26289. PubMed ID: 33960950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.
    Oosterhuis I; Taavola H; Tregunno PM; Mas P; Gama S; Newbould V; Caster O; Härmark L
    Drug Saf; 2018 Oct; 41(10):969-978. PubMed ID: 29761281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.
    Carnovale C; Raschi E; Leonardi L; Moretti U; De Ponti F; Gentili M; Pozzi M; Clementi E; Poluzzi E; Radice S
    Expert Rev Vaccines; 2018 Apr; 17(4):363-381. PubMed ID: 29452497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can mobile technologies improve on-time vaccination? A study piloting maternal use of ImmunizeCA, a Pan-Canadian immunization app.
    Atkinson KM; Westeinde J; Ducharme R; Wilson SE; Deeks SL; Crowcroft N; Hawken S; Wilson K
    Hum Vaccin Immunother; 2016 Oct; 12(10):2654-2661. PubMed ID: 27322109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.
    Bettinger JA; Rouleau I; Gariepy MC; Bowie WR; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; McNeil SA; McCarthy A; De Serres G;
    Euro Surveill; 2015 Jul; 20(29):21189. PubMed ID: 26227369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system.
    Newes-Adeyi G; Greece J; Bozeman S; Walker DK; Lewis F; Gidudu J
    Vaccine; 2012 Feb; 30(6):1050-5. PubMed ID: 22200501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.
    Regan AK; Blyth CC; Tracey L; Mak DB; Richmond PC; Effler PV
    Vaccine; 2015 Jul; 33(31):3689-94. PubMed ID: 26079616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid online identification of adverse events after influenza immunization in children by PCIRN's National Ambulatory Network.
    Bettinger JA; Vanderkooi OG; MacDonald J; Kellner JD
    Pediatr Infect Dis J; 2014 Oct; 33(10):1060-4. PubMed ID: 25361187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Kemmeren J; Honsbeek M; Dijkstra F; de Lange M; van der Maas N; Smallenburg R; Koppeschaar C; van der Hoek W
    Vaccine; 2016 Jul; 34(34):3961-6. PubMed ID: 27349839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
    Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
    Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.